Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
Royalty's $275M financing deal for Denali drug awaiting FDA nod
While Denali awaits a delayed FDA decision on its Hunter syndrome drug, the biotech is already banking on the therapy’s commercial success.
James Waldron
Dec 4, 2025 10:20am
Roche signs $2B pact to pilot Manifold's shuttles to the brain
Nov 3, 2025 8:45am
Irish biotech launches with $21M to shuttle RNAi meds to brain
Oct 1, 2025 10:34am
Galimedix's oral Alzheimer's candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
Acumen taps JCR’s brain barrier tech for $555M Alzheimer’s deal
Jul 15, 2025 8:01am
